Automation and Transparency across Financial and Legal services: Mitigating Risk, Enhancing Efficiency and Promoting Customer Retention through the Application of Voice and Emotional AI

金融和法律服务的自动化和透明度:通过应用语音和情感人工智能来降低风险、提高效率并促进客户保留

基本信息

  • 批准号:
    104817
  • 负责人:
  • 金额:
    $ 173.49万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Collaborative R&D
  • 财政年份:
    2019
  • 资助国家:
    英国
  • 起止时间:
    2019 至 无数据
  • 项目状态:
    已结题

项目摘要

"Insurance fraud costed the UK £3B in 2017, increasing 8% since 2015, equating to £10,400 per fraudulent claim. This causes an increase of £50 per policy. Current manual processes to identify illegitimate claims are repetitive, time-consuming, inefficient, non-user friendly with no consideration for vulnerable customers. This presents fraud identification as a primary target for developed AI capabilities.The public are becoming increasingly aware of voice activated AI following the release of Amazon's Echo: a market leader in the 'voice-controlled home'. Resultant scientific research surrounding this is focusing on adding intelligence to spoken commands for real-time information.Current advanced emotional AI technologies capture (non-verbal) human expressions via computer vision, voice analysis and/or biometric sensors. These lack processing speed and are unable to understand both vocalics and linguistics. No solution currently combines artificial intelligence and voice technology for a true conversation with full explainability of its decision.Addressing this gap, Intelligent Voice aim to develop an AI software that detects and interprets emotion and linguistics from voice. In collaboration with behavioural analysis experts at Strenuus and deep neural networks academics at University of East London, this project aims to develop a vocal AI technology for credibility/vulnerability assessment, key word spotting, in-call behavioural guidance and transparency of the decision-making process, trialled by an insurance contact centre during live claims handling. This will offer a breakthrough technology for the anti-fraud sector, simultaneously providing unique expertise to the UK in deep neural networks and AI with cross-sector potential.All partners are well placed to exploit this opportunity: Intelligent Voice have an existing global client-base for their voice recognition/transcription software in the financial/insurance services market, Strenuus completed Proof-of-Concept studies with their linguistic algorithms to assess credibility, successfully identifying deception, UEL has demonstrable expertise in data analytics, machine learning architecture and AI explainability. Insurance software providers are in place as in-kind contributors for exploitation.With InnovateUK support, a 30-month programme of Industrial Research and Experimental Development is required to develop behavioural analysis algorithms, explain the neural networks of the system, integrate the solution to ICE's existing platform and trial the technology in a controlled environment. Project success will support commercialisation by 2021, to establish:- Intelligent Voice at the forefront of the speech recognition software market, poised for significant growth;- Strenuus as a leader in behavioural analysis with novel audio processing algorithms;- UEL as a UK leading university with state-of-the-art explaining of DNNs."
2017年,保险欺诈给英国造成了30亿英镑的损失,自2015年以来增加了8%,相当于每起欺诈性索赔10,400英镑。这将导致每份保单增加50英镑。目前识别非法索赔的人工流程重复、耗时、效率低下、用户不友好,没有考虑到易受伤害的客户。这使得欺诈识别成为人工智能功能的主要目标。随着亚马逊Echo的发布,公众越来越意识到语音激活人工智能:“语音控制家庭”的市场领导者。目前先进的情感人工智能技术通过计算机视觉、语音分析和/或生物识别传感器捕捉(非语言)人类表情。他们缺乏处理速度,无法理解声乐和语言学。目前还没有解决方案将人工智能和语音技术结合起来,以实现真正的对话,并充分解释其决策。为了解决这一差距,智能语音旨在开发一种人工智能软件,可以从语音中检测和解释情感和语言。该项目与Strenuus的行为分析专家和东伦敦大学的深度神经网络学者合作,旨在开发一种语音AI技术,用于可信度/脆弱性评估、关键词识别、呼叫中行为指导和决策过程的透明度,并由保险联络中心在现场索赔处理过程中进行试验。这将为反欺诈领域提供突破性的技术,同时为英国提供具有跨行业潜力的深度神经网络和人工智能方面的独特专业知识。所有合作伙伴都有能力利用这一机会:智能语音在金融/保险服务市场拥有语音识别/转录软件的现有全球客户群,Strenuus用他们的语言算法完成了概念验证研究,以评估可信度,成功识别欺骗,UEL在数据分析,机器学习架构和AI可解释性方面拥有可证明的专业知识。在InnovateUK的支持下,需要一个为期30个月的工业研究和实验开发计划,以开发行为分析算法,解释系统的神经网络,将解决方案集成到ICE的现有平台上,并在受控环境中试用该技术。项目的成功将支持到2021年的商业化,以建立:-智能语音在语音识别软件市场的最前沿,准备显着增长;- Strenuus作为行为分析的领导者与新颖的音频处理算法;- UEL作为英国领先的大学与国家的最先进的DNN解释。"

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Studentship

相似海外基金

Generative AI toolkit to enforce regulatory requirements and enable capacity for increased corporate transparency.
生成式人工智能工具包,用于执行监管要求并提高企业透明度。
  • 批准号:
    10098889
  • 财政年份:
    2024
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Collaborative R&D
Securing Transparency And Reproducibility in studies of Nutritional interventions (STAR-Nut)
确保营养干预研究的透明度和可重复性 (STAR-Nut)
  • 批准号:
    MR/Z503824/1
  • 财政年份:
    2024
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Research Grant
Local Differential Privacy Technology with Guaranteed Transparency
本地差分隐私技术,保证透明度
  • 批准号:
    23K11110
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accident Investigation and Dispute Resolution Based on Patient Safety Principles - Toward Transparency and Communication
基于患者安全原则的事故调查和争议解决 - 实现透明度和沟通
  • 批准号:
    23H00773
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Augmenting participation, co-creation, trust and transparency in Deliberative Democracy at all scale
全面增强协商民主的参与、共同创造、信任和透明度
  • 批准号:
    10048874
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
    EU-Funded
IMPACT+ environmental Index Measures Promoting Assessment and Circular Transparency in fashion
IMPACT环境指数措施促进时尚界的评估和循环透明度
  • 批准号:
    NE/Y004035/1
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Research Grant
Crossroads: Using decision making strategies to develop high impact content for training in rigor and transparency.
十字路口:使用决策策略来开发高影响力的内容,以进行严格和透明的培训。
  • 批准号:
    10722510
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
Infrastructure and Services - Trust and Transparency
基础设施和服务 - 信任和透明度
  • 批准号:
    HDR-23003
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Intramural
Emergence transparency for enterprise agent-based models
基于企业代理的模型的出现透明度
  • 批准号:
    10066332
  • 财政年份:
    2023
  • 资助金额:
    $ 173.49万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了